Retrospective Review of Pediatric Psoriasis and TNF-Inhibitor Induced Psoriasiform Disease in Patients With Skin of Color
Open Access
- 28 May 2026
- journal article
- review article
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Abstract
Background: Psoriasis affects ~3% of the adult U.S. population, with known differences in prevalence, presentation, and treatment outcomes across racial and ethnic groups. In pediatric populations, disparities in psoriasis recognition may lead to delayed diagnosis and undertreatment, especially in patients with skin of color (SoC). Objectives: To compare clinical presentation and treatment patterns in pediatric patients with psoriasis with and without SoC at a single tertiary-care pediatric center. Methods: We conducted a retrospective, case–control cohort study of patients diagnosed with psoriasis (including TNF-associated psoriasis) before age 18 at SickKids Hospital (January 2008-March 2024). Inclusion criteria were systemic treatment before or after diagnosis of psoriasis and available photo documentation. Patients were stratified by skin phototype based on the Massey-Martin Scale for SoC. Demographics, clinical features, and treatment patterns were compared between SoC and non-SoC groups. Results: Among 115 patients, 42.6% were classified as SoC. Scalp involvement ( P = .008), inflammatory bowel disease ( P = .05), and arthritis were more common in non-SoC patients. SoC patients had a shorter time to diagnosis and were more likely to receive cyclosporine initially and methotrexate overall. Non-SoC patients had higher biologic use throughout care (77.2% vs 63.2%). Topical corticosteroids were the most prescribed treatment across both groups. Conclusions: Pediatric patients with and without SoC showed distinct trends in disease presentation and management. Differences in clinical presentation and medication use highlight the need for increased awareness of psoriasis manifestations in diverse skin types. Prospective studies with standardized assessment tools could help addressing the differences described in this study.Keywords
This publication has 12 references indexed in Scilit:
- Psoriasis in People With Skin of Color: An Evidence‐Based UpdateInternational Journal of Dermatology, 2025
- Black and male children have an increased risk of palmoplantar psoriasis compared to White childrenPediatric Dermatology, 2023
- Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United StatesGastroenterology, 2023
- Unmet Need in People with Psoriasis and Skin of Color in Canada and the United StatesDermatology and Therapy, 2022
- Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of colorJournal of the American Academy of Dermatology, 2022
- Transcriptome Analysis Reveals Intrinsic Proinflammatory Signaling in Healthy African American SkinJournal of Investigative Dermatology, 2021
- Paradoxical psoriasis in pediatric patients: A systematic reviewPediatric Dermatology, 2021
- Psoriasis Prevalence in Adults in the United StatesJAMA Dermatology, 2021
- Adalimumab-associated psoriasiform rash in an African-American patientBMJ Case Reports, 2020
- Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic GroupsAmerican Journal of Clinical Dermatology, 2017